FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Pauline Dürr
List of publications:
BibTeX-Download
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie
Award(s)
(1)
Publications
(16)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy (2024)
Cuba L, Dürr P, Dörje F, Fromm M, Schlichtig K
Journal article
Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center (2023)
Cuba L, Schlichtig K, Dürr P, Inwald EC, Fromm M, Dörje F
Journal article
Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs (2023)
Weisbach L, Schuster AK, Hartmann M, Dürr P, Then M, Andrikyan W, Fromm M, et al.
Journal article, Original article
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial (2022)
Dürr P, Meier F, Schlichtig K, Schramm A, Schötz L, Fromm M, Dörje F
Journal article
POLAR-POLypharmacy, drug interActions and Risks-how can data from inpatient care support their assessment? (2022)
Scherag A, Andrikyan W, Dreischulte T, Dürr P, Fromm M, Gewehr J, Jaehde U, et al.
Journal article
Drug Therapy Safety with new oral Antitumor Agents for the Therapy of Prostate and Renal Cell Carcinoma: Findings from the AMBORA Study (2022)
Cuba L, Schlichtig K, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al.
Conference contribution
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial (2022)
Schlichtig K, Cuba L, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al.
Journal article
Clarity, clinical applicability and relevance of absolute contraindications in official 'Summaries of Product Characteristics' (SmPCs) (2022)
Andrikyan W, Then M, Dürr P, Jung-Poppe L, Schuster A, Weisbach L, Farker K, et al.
Conference contribution
Development and validation of an LC-MS method for drug exposure measurement of 57 oral antitumor drugs in human plasma (2022)
Kehl N, Dürr P, Schlichtig K, Maas R, Fromm M, Geßner A, Taudte V
Conference contribution
Identification of diagnosis-related contraindications based on the medication plan alone (2022)
Andrikyan W, Then M, Gassmann KG, Tuemena T, Dürr P, Fromm M, Maas R
Conference contribution
‹
1
2
›